Ngā hua rapu - Jörg Trojan
- E whakaatu ana i te 1 - 20 hua o te 40
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
Systemic Therapy of Advanced Hepatocellular Carcinoma mā Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel
I whakaputaina 2020Revisão -
4
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer mā Jörg Trojan, Sebastian Stintzing, Oliver Haase, Christine Koch, Paul Ziegler, Melanie Demes, Ivan Jelas
I whakaputaina 2021Artigo -
5
Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study mā Fabian Finkelmeier, Bernd Kronenberger, Verena Köberle, Jörg Bojunga, Stefan Zeuzem, Jörg Trojan, Albrecht Piiper, Oliver Waidmann
I whakaputaina 2014Artigo -
6
Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success mā Thomas J. Vogl, N Naguib, Nour‐Eldin A. Nour‐Eldin, Wolf O. Bechstein, Stefan Zeuzem, Jörg Trojan, Tatjana Gruber‐Rouh
I whakaputaina 2011Artigo -
7
An augmented reality home-training system based on the mirror training and imagery approach mā Jörg Trojan, Martin Diers, Xaver Fuchs, Felix Bach, Robin Bekrater‐Bodmann, Jens Foell, Sandra Kamping, Mariela Rance, H. Maaß, Herta Flor
I whakaputaina 2013Artigo -
8
Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers mā Thomas J. Vogl, S Zangos, J Scholtz, Felix C. F. Schmitt, S. Christine Paetzold, Jörg Trojan, Franco Orsi, Gösta Lotz, Pier Francesco Ferrucci
I whakaputaina 2014Artigo -
9
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study mā Frank Kullmann, S. Hollerbach, Matthias Dollinger, Jan Harder, Martin Fuchs, Helmut Messmann, Jörg Trojan, E Gäbele, Axel Hinke, Cathérine Hollerbach, Esther Endlicher
I whakaputaina 2009Artigo -
10
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers mā Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U. Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier
I whakaputaina 2022Artigo -
11
The Importance of Synchrony and Temporal Order of Visual and Tactile Input for Illusory Limb Ownership Experiences – An fMRI Study Applying Virtual Reality mā Robin Bekrater‐Bodmann, Jens Foell, Martin Diers, Sandra Kamping, Mariela Rance, Pinar Kirsch, Jörg Trojan, Xaver Fuchs, Felix Bach, Hüseyin Çakmak, H. Maaß, Herta Flor
I whakaputaina 2014Artigo -
12
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial mā Oliver Nehls, Helmut Oettle, J. T. Hartmann, R. D. Hofheinz, H G Hass, Marius Horger, Ursula Koppenhöfer, Andreas Hochhaus, Jens Stieler, Jörg Trojan, Michael Gregor, Bodo Klump
I whakaputaina 2008Artigo -
13
Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth mā Uta Rabenhorst, Rasa Beinoravičiūtė-Kellner, M.-L. Brezniceanu, Stefan Joos, Frauke Devens, Peter Lichter, Ralf J. Rieker, Jörg Trojan, Hye Jung Chung, David Levens, Martin Zörnig
I whakaputaina 2009Artigo -
14
Transarterial chemoembolization of unresectable systemic chemotherapy‐refractory liver metastases from colorectal cancer: Long‐term results over a 10‐year period mā Tatjana Gruber‐Rouh, N Naguib, Katrin Eichler, Hanns Ackermann, Stephan Zangos, Jörg Trojan, Martin Beeres, Marc Harth, Boris Schulz, Nour‐Eldin Nour‐Eldin A., Thomas J. Vogl
I whakaputaina 2013Artigo -
15
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions mā Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas Eigentler, Marc‐Oliver Grimm, Victor Grünwald, Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer, Ralf Gutzmer
I whakaputaina 2017Revisão -
16
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial mā Stefan Boeck, K. Weigang-Köhler, Martin Fuchs, E. Kettner, D. Quietzsch, Jörg Trojan, Oliver Stötzer, Stefan Zeuzem, Florian Lordick, C-H Köhne, H. Kröning, Tilmann Steinmetz, H. Depenbrock, Volker Heinemann
I whakaputaina 2007Artigo -
17
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer mā Maren Knödler, Justus Körfer, Volker Kunzmann, Jörg Trojan, S Daum, Michael Schenk, Frank Kullmann, Sebastian Schroll, Dirk Behringer, Michael Stahl, Salah‐Eddin Al‐Batran, Ulrich Hacker, Stefan Ibach, Horst Lindhofer, Florian Lordick
I whakaputaina 2018Artigo -
18
Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma mā Verena Bihrer, Oliver Waidmann, Mireen Friedrich‐Rust, Nicole Forestier, S. Süsser, Jörg Haupenthal, Martin Welker, Yongyong Shi, Jan Peveling‐Oberhag, Andreas Polta, Michael Wagner, Heinfried H. Radeke, Christoph Sarrazin, Jörg Trojan, Stefan Zeuzem, Bernd Kronenberger, Albrecht Piiper
I whakaputaina 2011Artigo -
19
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer mā Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, Denis Pezet, G. Deplanque, Martin Fuchs, Jörg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero
I whakaputaina 2018Artigo -
20
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies mā Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, Thomas Berg, Arndt Vogel, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Anja Eiblmaier, Hanns‐Georg Klein, Johannes Kolja Hegel, Kairat Madin, Konstantin Kroeniger, Ashish Sharma, Henry Lik‐Yuen Chan
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Oncology
Cancer
Gastroenterology
Hepatocellular carcinoma
Chemotherapy
Immunotherapy
Computer science
Phases of clinical research
Colorectal cancer
Gemcitabine
Sorafenib
Clinical endpoint
Immunology
Surgery
Adverse effect
Biology
Cancer research
Chemistry
Clinical trial
Cohort
Confidence interval
Hazard ratio
Immune checkpoint
Pathology
Randomized controlled trial
Nivolumab
Oxaliplatin
Pancreatic cancer